{
  "id": 19900496,
  "title": "Oruka Therapeutics SVP sells $1.05M in shares",
  "url": "https://urgent.news/2026/11/14/oruka-therapeutics-svp-sells-1-05m-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-14T01:35:20.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/oruka-therapeutics-svp-sells-105m-in-shares-93CH-5026892"
  },
  "original_language": "en",
  "account": null,
  "summary": "Oruka Therapeutics' Senior Vice President of Finance, Arjun Agarwal, sold $1.05 million worth of the company's common stock on November 12, 2026, as part of a pre-arranged Rule 10b5-1 trading plan. The shares were sold at prices between $101.28 and $107.0 per share, with the stock currently trading at $105.35, near its 52-week high. Agarwal also acquired 10,000 shares through employee stock options, totaling approximately $156,915. The company has recently reported positive clinical trial data for its psoriasis treatment, ORKA-001, which has received renewed interest from analysts despite a decline in stock price.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}